Entera

JERUSALEM, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today reported corporate updates and financial…

JERUSALEM, May 05, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd.…

JERUSALEM, March 31, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd.…

JERUSALEM, March 23, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd.…

<!-- Name:DistributionId Value:8747979 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…